Drug Shortage Report for ADYNOVATE
Report ID | 163980 |
Drug Identification Number | 02498537 |
Brand name | ADYNOVATE |
Common or Proper name | Antihemophilic Factor (Recombinant), Pegylated |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTIHEMOPHILIC FACTOR |
Strength(s) | 250UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS |
Packaging size | 2 mL Vial |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-06-30 |
Actual start date | 2022-06-30 |
Estimated end date | 2022-09-30 |
Actual end date | 2022-09-21 |
Shortage status | Resolved |
Updated date | 2022-09-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-09-22 | English | Compare |
v6 | 2022-09-21 | French | Compare |
v5 | 2022-09-21 | English | Compare |
v4 | 2022-07-01 | English | Compare |
v3 | 2022-06-30 | French | Compare |
v2 | 2022-06-30 | English | Compare |
v1 | 2022-06-30 | English | Compare |
Showing 1 to 7 of 7